Valuentum Exclusive Analysis for the Discerning Investor

Symbol Keyword

Member Login Email Password Join Now Forgotten Password Newsletters/Portfolios View Current and Archived Dividend Growth Newsletters View Current and Archived Best Ideas Newsletters Valuentum's Dividend Growth Newsletter Portfolio Valuentum's Best Ideas Newsletter Portfolio Order the Exclusive Publication! View Current and Archived Exclusive Editions Order the High Yield Dividend Newsletter! Dividend Cushion Efficacy Calculation Dividend-Adjusted Leverage White Paper Stock Screens How to Filter Data in Microsoft Excel Like a Pro Download Weekly Stock Screener (xls) -- login required The Quarterly DataScreener Products & Tools Financial Advisor (GOLD LEVEL) Publications DCF Valuation Model Template Order Value Trap Order Value Trap, second edition Value Trap Order PDF Copy Order Paperback Copy Presentation BookLife Review BlueInk Review Foreword Review Readers' Favorite Review Axiom Bronze Praise The Buying Index, VBI Value and Momentum Within Stocks, Too (2017) The Case for the Valuentum Style of Investing (2012) Investing's Odd Couple: Value and Momentum (2013) Stock-Selection Methodology, the Valuentum Buying Index (2011) Why Valuentum Buying Index Ratings Matter (2014) Dividend Changes Dividend Increases/Decreases for the Week of November 8 Dividend Increases/Decreases for the Week of November 1 Dividend Increases/Decreases for the Week of October 25 Dividend Increases/Decreases for the Week of October 18 Dividend Increases/Decreases for the Week of October 11 Dividend Increases/Decreases for the Week of October 4

Results 131 - 140 of 208 for neu. (0.96 seconds) Update: Digging Into the Valuentum Dividend Cushion We explain our innovative, predictive, and... Dividend Growth Gem Medtronic Is a Cash Cow Full-year free cash flow of $4.4 billion confirms that... Main Street’s Solid Run Continues Book value and net investment income increase at Main... If Yields Go Up, Are BDCs Done For? Let’s take a look at Main Street and the BDC... Generic Pharmaceuticals: Patent Expiration and Low Global Utilization Rates Create Opportunities Big Pharma is not dead, but neither are the generics.... Weak Volume Growth Weighs on Coca-Cola Volume growth at Coca-Cola was relatively weak, but we... Strong Second Quarter Results at Johnson & Johnson Johnson & Johnson exceeded second quarter... Amgen’s Second Quarter Doesn’t Disappoint Amgen posted a solid second quarter, but we think shares... Gold Is But a Shiny Yellow Metal Image shown: The performance of an ETF tracking the... Tyson, ConAgra, Hershey, and Cal-Maine Lead the Pack The food products industry is a mixed bag, with mature... prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | next